The increasing overdoses death in the United States is an issue that worries health care authorities and bioethicists. Are prevention campaigns obtaining positive results? Can health care regulations improve? Can doctors do better in the prescription of these drugs? What is the prognosis of this epidemic? These questions are unresponded.

In this respect, we commented last July an article published in The New York Times entitled “In Shadow of Pandemic, U.S. Drug Overdose Deaths Resurge to Record.” Our article mainly treated opioid epidemic evolution.

Evolution of drug overdoses deaths related to cocaine

A large study of the National Center for Health Statistics – NCHS has been published this month, given the last official figures of cocaine (read HERE). We can follow the evolution in the last years and observe the trend of an issue that also appears to be uncontrolled.

Deaths involving cocaine in 2018 were more than triple the rate in 2009

The Summary of the NCHS Data Brief of this month says, “This report updates statistics on drug overdoses deaths evolution involving cocaine in the United States, including information on trends from 2009 through 2018. After remaining stable from 2009 through 2013, rates of drug overdose deaths involving cocaine increased on average by about 27% per year from 2013 through 2018. The rate of drug overdose deaths involving cocaine in 2018 was more than triple the rate in 2009 (4.5 and 1.4 per 100,000, respectively).” […] Finally, a key factor in the recent rise in deaths due to cocaine is the concurrent involvement of opioids. From 2013 to 2018, the rate of drug overdose deaths involving cocaine with concurrent opioid involvement increased at a faster pace than the rate for deaths without concurrent opioid involvement.”

Following, we publish a graphic about the drug crisis and the incidence of some drugs